# Indivior PLC to Participate in Jefferies 2019 Healthcare Conference

- Link: https://www.directorstalkinterviews.com/indivior-plc-to-participate-in-jefferies-2019-healthcare-conference/412782544
- Published: 2019-05-16T08:02:05+01:00
- Author: Charlotte Edwards

**Indivior PLC** (LON: INDV) today announced that Shaun Thaxter, Chief Executive
Officer, and Mark Crossley, Chief Financial Officer, will participate in Jefferies
2019 Healthcare Conference taking place in New York City on June 4 to 7, 2019.

On Tuesday, June 4th at 10:30 a.m. EST, Thaxter will discuss Indivior’s strategy
and outlook. His remarks will be webcast live and the broadcast will be available
on the “Investors” section of Indivior’s [website](http://www.indivior.com) under“
Webcasts / Audiocasts / Presentations.” If you plan to listen to the live webcast,
please allow sufficient time to register and download any audio software required
to access the discussion.

**About Indivior**

Indivior is a global specialty pharmaceutical company working to change patient 
lives by pioneering life-transforming treatment for addiction and other serious 
mental health diseases. Our Vision is that all patients around the world will have
access to evidence-based treatment for the chronic conditions and co-occurring disorders
of addiction. Indivior is dedicated to transforming addiction from a global human
crisis to a recognized and treated chronic disease. Building on its global portfolio
of opioid dependence treatments, Indivior has a strong pipeline of product candidates
designed to both expand on its heritage in this category and address other chronic
conditions and co-occurring disorders of addiction, including alcohol use disorder
and schizophrenia. Headquartered in the United States in Richmond, VA, Indivior 
employs more than 800 individuals globally and its portfolio of products is available
in over 40 countries worldwide. Visit www.indivior.com to learn more.

Share on: